Global Erythrocyte Sedimentation Rate (ESR) Tubes Market Size, Share, and COVID-19 Impact Analysis, By Material Type (Glass and Plastic), By End-User (Specialty Centers, Hospitals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Global Erythrocyte Sedimentation Rate (ESR) Tubes Market Insights Forecasts to 2033

• The Global Erythrocyte Sedimentation Rate (ESR) Tubes Market Size was Estimated at USD 118.47 Million in 2023
• The Market Size is Expected to Grow at a CAGR of around 5.53% from 2023 to 2033
• The Worldwide Erythrocyte Sedimentation Rate (ESR) Tubes Market Size is Expected to reach USD 202.88 Million by 2033
• Asia Pacific is predicted to Grow at the fastest CAGR throughout the projection period

The Global Erythrocyte Sedimentation Rate (ESR) Tubes Market Size is anticipated to Exceed USD 202.88 Million by 2033, Growing at a CAGR of 5.53% from 2023 to 2033. The market growth is attributed to the rising occurrence of chronic conditions that cause inflammation, technological advancements, and rising demand for ESR tubes for the conduct of ESR tests.

Market Overview

The erythrocyte sedimentation rate (ESR) tube market encompasses the manufacturing and distribution of the ESR tubes used while conducting the erythrocyte sedimentation rate test. An erythrocyte sedimentation rate (ESR) test is a haematology test that measures the rate at which red blood cells sink to the bottom of a test tube over an hour. High levels of inflammation are indicated by a high settlement rate. The ESR test is commonly performed to monitor an increase in inflammatory activity caused by conditions like autoimmune disease, infections, or tumors. It is not specific to any single disease but is used in combination with other tests to determine the presence of increased inflammatory activity. The ESR has long been used as a "sickness indicator" owing to its reproducibility and low cost.

The increasing prevalence of inflammatory diseases and the chronic conditions that are associated with inflammation escalates the need for the ESR blood test that alleviates the demand for the ESR tubes, resulting in market expansion. For example, the data provided by the World Health Organization states that rheumatoid arthritis is a chronic condition characterized by inflammation throughout the body, frequently manifests as joint discomfort, and requires proper diagnosis and treatment. ESR blood test is mostly recommended by healthcare professionals as a diagnostic test for the evaluation of the intensity of inflammation in the body. In 2019, 18 million people worldwide were affected by rheumatoid arthritis, with 70% being women and 55% aged over 55, and 13 million individuals experienced moderate or severe severity levels that could benefit from rehabilitation.

The rising incidence of inflammatory and chronic illnesses throughout the world is driving growth in the erythrocyte sedimentation tube market. The need for these tubes is fueled by the regular ESR tests required for the diagnosis and monitoring of these conditions. The incidence of these chronic illnesses is predicted to increase as the world's population ages, which will further propel market expansion. The market is expanding as a result of technological developments like automated ESR analyzers, which improve the tests' accuracy and dependability.

Report Coverage

This research report categorizes the global erythrocyte sedimentation rate (ESR) tubes market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the global erythrocyte sedimentation rate (ESR) tubes market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the global erythrocyte sedimentation rate (ESR) tubes market.

Driving Factors:

Proliferation in the geriatric population:

Globally, the proportion of the geriatric or aged population is rising, which promotes a high risk of occurrence of chronic conditions such as cardiovascular, gastrointestinal, and orthopedic diseases, etc., due to weakened muscles, alterations in the immunity function, and wear and tear of arteries and blood vessels. Considering all aspects, it states that the geriatric population is more susceptible to chronic diseases, which requires frequent diagnostic tests and haematological testing, particularly ESR tests leading to escalate the demand for ESR tubes resulting in to the market growth.

Technological advancements in the ESR tubes:

Researchers and manufacturing companies are focusing on the production of ESR tubes, with the introduction of polymer-based substitutes such as polystyrene or polyethylene increasing longevity and decreased the chance of contamination and breakage. The growing use of biodegradable materials supports sustainability objectives. Anticoagulant coatings on contemporary tubes assist to keep samples stable and stop blood clotting. Automated mixing methods minimize manual intervention by ensuring consistent anticoagulant dispersion. Accurate sample tracking and documentation are made easier by barcoding and smart labeling solutions, which lower diagnostic errors.

Restraining Factors

The presence of another diagnostic test for the evaluation of hematological testing, such as the polymerase chain reaction (PCR) technique and high-throughput sequencing, and lack of awareness in low-middle-income countries may impede the market growth.

Market Segmentation

The global erythrocyte sedimentation rate (ESR) tubes market share is classified into material type and end-user.

• The glass segment dominated the global erythrocyte sedimentation rate (ESR) tubes in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period.

Based on the material type, the global erythrocyte sedimentation rate (ESR) tubes market is categorized into glass and plastic. Among these, the glass segment dominated the global erythrocyte sedimentation rate (ESR) tubes in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period. The segmental expansion is owing to ideal tubes for the storage of long-term samples, accurate blood test results, reliability, highly durable, resistant to chemicals, compatible feature, precise measurement due to clarity of glass, and retains the moisture.

• The hospitals segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.

Based on the end-user, the global erythrocyte sedimentation rate (ESR) tubes market is categorized into specialty centers, hospitals, and others. Among these, the hospitals segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segment dominance is facilitated by the ESR tests, which are crucial for the diagnosis and continual surveillance of diseases such as cancer, autoimmune disorders, and infections. A regular availability of sedimentation tubes is necessary for the integration of ESR testing into hospital workflows. It is anticipated that the growing use of sophisticated diagnostic technology, hospital admissions worldwide, and facility expansion.

Regional Segment Analysis of the Global Erythrocyte Sedimentation Rate (ESR) Tubes Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global erythrocyte sedimentation rate (ESR) tubes market over the predicted timeframe.

North America is anticipated to hold the largest share of the global erythrocyte sedimentation rate (ESR) tubes market over the predicted timeframe. This is ascribed to advanced healthcare infrastructure, high chronic disease prevalence, and substantial healthcare expenditure. Major diagnostic equipment manufacturers and widespread adoption of advanced technologies contribute to the market. Government initiatives and high healthcare expenditure also contribute to the demand for ESR tubes.

Asia Pacific is anticipated to grow at the fastest CAGR throughout the projected timeframe. The growth of the ESR tubes market is driven by the development of healthcare infrastructure, increasing chronic disease prevalence, and rising healthcare expenditure in countries like China, India, and Japan. The expanding network of clinical laboratories and diagnostic centers and government initiatives for early disease diagnosis are expected to further support this growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global erythrocyte sedimentation rate (ESR) tubes market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Thermo Fisher Scientific, Inc.
• Hema Technologies
• Vital Diagnostics
• SFRI Medical Diagnostics
• LabCorp
• APExBIO
• Medline Industries, Inc.
• Cardinal Health, Inc.
• Drucker Diagnostics
• Becton, Dickinson and Company
• Streck, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In June 2024, Horiba launched the new model of Erythrocyte Sedimentation Rate (ESR). The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) now offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds, adding a comprehensive profile for inflammatory disease assessment to the instrument's already extensive functionality.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global erythrocyte sedimentation rate (ESR) tubes market based on the below-mentioned segments:

Global Erythrocyte Sedimentation Rate (ESR) Tubes Market, By Material Type

• Glass
• Plastic

Global Erythrocyte Sedimentation Rate (ESR) Tubes Market, By End-User

• Specialty Centers
• Hospitals
• Others

Global Erythrocyte Sedimentation Rate (ESR) Tubes Market, By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa